SHARE:
AWS and SAP: How and Why Companies
Run Regulated Workloads in the Cloud
2
C
hange is the only constant in today's
b i o p h a r m a i n d u s t r y. To s u c c e e d ,
c o m p a n i e s m u s t c o l l a b o r a t e a n d
outmaneuver the competition against a
backdrop of fast-evolving regulations and technologies.
Being nimble is essential. To help companies achieve
this state, Amazon Web Services has partnered with
SAP. Multi-year upgrade projects are out. Rapid
iteration is in.
For years, biopharma companies have relied on
AWS and SAP to support different parts
of their operations. The AWS cloud has
enabled preclinical researchers, marketing
teams and other groups to store, share and
analyze data, innovate and collaborate while
freeing themselves from the costs and constraints
of on-premise infrastructure.
In parallel, SAP has reimagined its enterprise resource
planning (ERP) system for the digital era. Today, data
generated and collected through the networking of
businesses, processes, data and equipment makes it
possible for companies to gather real-time insights
that improve their operations. These insights are a key
differentiator in the fast-moving digital economy but
accessing them using legacy systems is challenging.
SAP responded to these challenges with HANA,
a platform that adds real-time computing to the
features that made its traditional ERP system perhaps
the most mission critical suite of applications run
by businesses.
In 2017, AWS and SAP par tnered to
a c c e l e r ate t h e c onve rge n c e of t h e i r
offerings. The result is a faster and simpler
way to move from on-premise hardware
and get started with SAP HANA in the AWS
cloud. Companies can bring their own licenses and
software to the AWS cloud. The perceived barriers
to running regulated workloads in the cloud have
fallen away.
Established companies that make the migration and
startups that skip the on-premise era and go straight to